Tuomas Mirtti

32PUBLICATIONS
182CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsMedical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 01, 2026
Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.

|Feb 04, 2026
Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models.

Neja Sirc, Johannes Smolander, Anita N Kumari

|Dec 01, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

Sebastian Medina, Naoto Tokuyama, Kamal Hammouda

|Nov 11, 2024
pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy.

Piotr Bialas, Tamae Kobayashi, Rebecka Hellsten

|Oct 19, 2024
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.

Matilda Roos-Mattila, Pauliina Kallio, Tamara J Luck

|Mar 20, 2024
Protocol liver biopsy predicts graft survival after liver transplantation.

Ville H Liukkonen, Arno J Nordin, Martti A Färkkilä

Pageof 6

Frequent Collaborators

11 joint publications

Antti Sakari Rannikko

5 joint publications

Petrus Järvinen

4 joint publications

Harry Nisen

4 joint publications

Andrew M Erickson